Navigation Links
Extra care for outwardly healthy workers costs companies millions annually

ANN ARBOR, Mich.---Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs.

A new University of Michigan study shows workers with metabolic syndrome (MetS) and associated chronic disease can cost employers up to $5,867 annually in health care, pharmacy and short term disability---compared to $1,600 for a healthy worker. But the good news: Companies can stop those chronic health problems before they start.

MetS is a collection of health risks that includes body mass index, cholesterol, glucose, blood pressure and triglycerides. The study was designed to determine the relationship between MetS and disease among employed adults. Researchers at the Health Management Research Center in the U-M School of Kinesiology gave health risk assessments to 3,285 employees in a Midwestern manufacturing company in 2004, and again in 2006. They hoped to determine whether employees with MetS would develop one of five chronic conditions (heart disease, diabetes, chronic pain, heartburn, or arthritis) associated with MetS.

People in the general population with MetS are known to be more likely to develop health problems such as heart disease and diabetes without health intervention, says research associate and study author Alyssa Schultz, but this is the first time the link has been studied and shown in working populations.

This surprising finding challenges the so-called "healthy worker" effect. Researchers found that the workers in the study were just as likely to develop heart disease and diabetes as the general population. This finding defies the prevailing wisdom that working people are healthier and more insulated from disease than the unemployed, says Schultz.

"We didn't know if employees with MetS would also have disease but they do," Schultz said. "This shows disease is an issue for corporations and other organizations, and they need to take action to help employees stay healthy.

"People with MetS cost employers money, but people with MetS and disease cost a lot more," Schultz said.

Employees with MetS were significantly more likely to report arthritis, chronic pain, diabetes, heartburn and heart disease, Schultz says. Also, if someone had MetS in 2004, they were much more likely to develop one of the associated chronic conditions by the second test in 2006.

"The important thing for employers is to catch employees who have the risk factors before it escalates to a disease state," she said. "Keeping people healthy is much wiser then treating the illness or disease after it occurs."

The first step for employers says Schultz, is a health risk appraisal to determine the health of employees. When at-risk employees are identified, a prevention and intervention programs can cost as little as $150 a year per employee, according to a source in the paper.

"If individuals take advantage of programs helping them to both maintain their low risks and reduce their high risks, their odds of experiencing disease will be reduced," she said. "This leads to improved vitality and quality of life for individuals, and cost avoidance for corporations in the form of lower health care, pharmacy and short term disability costs.


Contact: Laura Bailey
University of Michigan

Related medicine news :

1. Extra Hour to Prepare: APHA Reminds You to Check Emergency Stockpile Kits When Setting Your Clocks on Nov. 1
2. Court Imposes Record Fine and Forfeiture of $1.3 Billion for Pharmacia & Upjohn Companys Fraudulent Marketing of Bextra
3. Choyce Peterson Goes the Extra Mile for Visiting Nurses
4. Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants
5. Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection
6. SEIU Local 721 Calls for Attorney General to Investigate Self-Dealing and $22 Million in Extra Costs at Tarzana Treatment Center
7. 85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Cant See Past a Few Extra Pounds, States
8. HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimers Disease
9. Bextra Whistleblower Case Started Investigation of Pfizer
10. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
11. Going Back to School With Asthma Takes Extra Work
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb ... the leading plastic surgery practices in Florida, is proud to announce that Dr. ... surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational New Drug ... so important to this key industry segment, Regis Technologies has decided to sponsor and ... 4th at 11am EST. , Federal law does not allow new drugs to cross ...
(Date:11/30/2015)... ... November 30, 2015 , ... Healthjump, Inc. ... Inc., a Healthcare IT consulting, development and support company. The purchase will expand ... available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and artists were ... held on November 8th and 9th at the Puerto Rico Convention Center, San Juan ... beauticians and top of the line fashion journalists. The San Juan Beauty Show carries ...
(Date:11/30/2015)... ... 2015 , ... Innovaacom, a leading provider of medical education ... of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, Asia, ... online and face-to-face education for pharmacists who are fast becoming the new “gatekeepers” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... 2015 Elbit Imaging Ltd. (TASE, ... today that it was informed by InSightec Ltd. ("InSightec"), that ... has approved its Exablate Neuro system to treat movement, ... --> Insightec,s Exablate Neuro platform is transforming ... two technologies: Focused Ultrasound, which is used to lesion ...
Breaking Medicine Technology: